Journal Menu


Drug Invention Today
ISSN NO: 0975-7619
Drug Invention Today (DIT) was first published in 2009 by JPR Solutions. It is a journal, which publishes reviews, research papers and short communications . From 2019  Journal will be monthly twice ( vol 11& 12 with 2 Issues per month)
• Novel Drug Delivery Systems • Nanotechnology & Nanomedicine • Biotechnology related pharmaceutical technology • Polymeric bio-conjugates • Biological macromolecules • Biomaterials • Drug Information • Drug discovery/development • Screening of drugs from natural & synthetic origins • Novel therapeutic strategies • Combinatorial chemistry and parallel synthesis • Clinical trials • Case Reports
 Impact FactorTM ( India ) = 0.895 as on date (09.11.2018)
Indexed in
NCBI NLM Catalogue,
SCOPUS, EMBASE (Elsevier),
ROAD, CABI, Google Scholar,
Open J-Gate, Biblioteca,
Science Central,
Index Scholar, Indian Citation Index,
 AYUSH Research Portal, 
Indexed Copernicus, EBSCO, PSOAR,
Ulrichs Directory of Periodicals, etc.

Manuscripts Published

Journal: Drug Invention Today , Volume: 3, Issue: April
Article Id: JPRS-CR(D)-0000909
Title: Prescribing Patterns of antihypertensive drugs in a South Indian tertiary care hospital
Category: Case Reports (Drugs)
Section: Research Article
Author Affiliation: Department of Pharmacology, Kasturba Medical College, Mangalore, Manipal University, Karnataka, India
View Article

Introduction:.The choice of drug for the treatment of hypertension changes at short intervals. Drug utilization studies conducted at regular intervals help to guide the physician in prescribing drugs rationally. The present study was done to analyze the prescribing patterns of antihypertensive drugs in a South Indian tertiary care hospital. Methods: A retrospective, cross sectional analysis of prescriptions of antihypertensive cases admitted in Medicine in-patient wards of Kasturba Medical College Hospital, Attavar, Mangalore, India during the period of January 2010 to July 2010 was conducted. All the prescription files with diagnosis of essential hypertension (ICD-9CM: 401-405, WHO international code: A 26) were analyzed. Prescriptions for hypertension with other co-morbid conditions were also included. Frequency and proportions of utilization of antihypertensive medications were charted and figured. Results: During the study period, there were 200 prescriptions for essential hypertension. The most frequently prescribed antihypertensive medications were: Calcium channel blockers (49%) followed by diuretics (43.5%), angiotensin converting enzyme inhibitors (29.5%) beta blockers (29%)and angiotensin receptor blockers (21%). 51% of patients were on multiple drug therapy, the most favored fixed drug combination being diuretics with angiotensin receptor blockers (25.4%). Among the hypertensive cases with co-existing diabetes mellitus type II, the most prescribed class of drugs was diuretics (43.8%) followed by angiotensin converting enzyme inhibitors (40.4%). Conclusion:The present study represents the current prescribing trend for antihypertensive agents. It implies that calcium channel blockers are the leading group of antihypertensive agents followed by diuretics.